The extract of the leaves of Ginkgo biloba, a popular dietary supplement, may offer some therapeutic benefits in fighting Type 2 diabetes, according to a study co-authored by a researcher at the University of Cincinnati (UC) College of Medicine. “In diabetic rats Ginkgo biloba had a very good effect on the beta cells of Langerhans […]
Home »
Estrogen improves Parkinson’s disease symptoms: Insight into sex-based differences could lead to new treatments
Brain-selective estrogen treatment improves the symptoms of Parkinson’s disease in male mice, according to new research published in JNeurosci. These findings may help explain the sex differences in Parkinson’s disease and could lead to estrogen-based treatments. Parkinson’s disease is characterized by the death of neurons involved in movement, which may be partially caused by gene […]
Another possible consequence of the opioid epidemic: hormone deficiencies
Many people who use opioid medications long term do not produce enough testosterone or another important hormone, cortisol, according to a new study. Results of what the researchers called “the most up-to-date and most comprehensive clinical review of endocrine effects of long-term opioid use” are being presented Sunday at ENDO 2019, the Endocrine Society’s annual […]
New aid to help identify and manage patients with diabetes at increased risk of fracture
Fragility fractures are a serious yet neglected complication of both type 1 and type 2 diabetes, with increased risk of fragility fractures in people with diabetes extending across the life span. This is a concern as, globally, the prevalence of diabetes in adults is expected to increase from almost 425 million today, to approximately 629 […]
Early type 1 diabetes shortens women’s lives by 18 years
Women who developed type 1 diabetes before the age of ten years die an average of nearly 18 years earlier than women who do not have diabetes. Men in the corresponding situation lose almost 14 years of life. The lives of patients diagnosed at age 26-30 years are shortened by an average of ten years, […]
Alzheimer’s disease and type 2 diabetes: Hope for inhibitors against amyloid plaques: Designed peptides as potential inhibitors of amyloid plaques
Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer’s disease and type 2 diabetes are not yet available. Scientists at the Technical University of Munich (TUM) have now come a little bit closer to a solution: They have described a new class of designed macrocyclic peptides that are highly potent inhibitors of amyloid […]
Why weight loss produces remission of type 2 diabetes in some patients
A clinical trial recently showed that nearly half of individuals with type 2 diabetes achieved remission to a non-diabetic state after a weight-loss intervention delivered within 6 years of diagnosis. Now a study published August 2nd in the journal Cell Metabolism reveals that this successful response to weight loss is associated with the early and […]
Air pollution contributes significantly to diabetes globally: Even low pollution levels can pose health risk
New research links outdoor air pollution — even at levels deemed safe — to an increased risk of diabetes globally, according to a study from Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) St. Louis Health Care System. The findings raise the possibility that reducing pollution may lead to a […]